Adia Nutrition Inc. Celebrates Grand Opening of Adia Med of San Antonio, First Licensed Clinic, Led by Michele DeLeon MD
Adia Nutrition Inc. (OTCQB: ADIA) has announced the grand opening of its first licensed clinic, Adia Med of San Antonio, located in Texas. The clinic, led by Dr. Michele DeLeon, will offer FDA-registered regenerative medicine products including AdiaVita (containing 100 million viable cells and 3 trillion exosomes per unit) and AdiaLink (3.5 trillion exosomes per unit).
The new facility will collaborate with Adia Med of Winter Park on a clinical study investigating regenerative therapies for autism. The company is actively expanding its network through licensing opportunities, marking this opening as a strategic milestone in its growth plan.
Adia Nutrition Inc. (OTCQB: ADIA) ha annunciato l'inaugurazione della sua prima clinica autorizzata, Adia Med di San Antonio, situata in Texas. La clinica, guidata dalla Dottoressa Michele DeLeon, offrirà prodotti di medicina rigenerativa registrati dalla FDA, inclusi AdiaVita (contenente 100 milioni di cellule vitali e 3 trilioni di esosomi per unità) e AdiaLink (3,5 trilioni di esosomi per unità).
La nuova struttura collaborerà con Adia Med di Winter Park in uno studio clinico che indaga le terapie rigenerative per l'autismo. L'azienda sta espandendo attivamente la sua rete attraverso opportunità di licenza, segnando questa apertura come una tappa strategica nel suo piano di crescita.
Adia Nutrition Inc. (OTCQB: ADIA) ha anunciado la inauguración de su primera clínica autorizada, Adia Med de San Antonio, ubicada en Texas. La clínica, dirigida por la Dra. Michele DeLeon, ofrecerá productos de medicina regenerativa registrados por la FDA, incluyendo AdiaVita (que contiene 100 millones de células viables y 3 billones de exosomas por unidad) y AdiaLink (3.5 billones de exosomas por unidad).
La nueva instalación colaborará con Adia Med de Winter Park en un estudio clínico que investiga terapias regenerativas para el autismo. La empresa está ampliando activamente su red mediante oportunidades de licenciamiento, marcando esta apertura como un hito estratégico en su plan de crecimiento.
Adia Nutrition Inc. (OTCQB: ADIA)는 텍사스에 위치한 첫 번째 허가 클리닉인 Adia Med of San Antonio의 정식 개원을 발표했습니다. Dr. Michele DeLeon이 이끄는 이 클리닉은 FDA 등록 재생 의학 제품인 AdiaVita (단위당 1억 개의 생존 세포와 3조 개의 엑소좀 포함)와 AdiaLink (단위당 3.5조 개의 엑소좀)를 제공합니다.
새 시설은 자폐증 재생 치료법을 연구하는 임상 시험을 위해 Adia Med of Winter Park와 협력할 예정입니다. 회사는 라이선스 기회를 통해 네트워크를 적극 확장 중이며, 이번 개원을 성장 계획의 전략적 이정표로 삼고 있습니다.
Adia Nutrition Inc. (OTCQB : ADIA) a annoncé l'ouverture officielle de sa première clinique agréée, Adia Med de San Antonio, située au Texas. La clinique, dirigée par la Dr Michele DeLeon, proposera des produits de médecine régénérative enregistrés auprès de la FDA, comprenant AdiaVita (contenant 100 millions de cellules viables et 3 trillions d'exosomes par unité) et AdiaLink (3,5 trillions d'exosomes par unité).
Cette nouvelle installation collaborera avec Adia Med de Winter Park dans le cadre d'une étude clinique portant sur les thérapies régénératives pour l'autisme. L'entreprise développe activement son réseau via des opportunités de licence, faisant de cette ouverture une étape stratégique dans son plan de croissance.
Adia Nutrition Inc. (OTCQB: ADIA) hat die feierliche Eröffnung seiner ersten lizenzierten Klinik, Adia Med of San Antonio, in Texas bekannt gegeben. Die Klinik unter der Leitung von Dr. Michele DeLeon wird von der FDA zugelassene regenerative Medizinprodukte anbieten, darunter AdiaVita (mit 100 Millionen lebensfähigen Zellen und 3 Billionen Exosomen pro Einheit) und AdiaLink (3,5 Billionen Exosomen pro Einheit).
Die neue Einrichtung wird mit Adia Med of Winter Park an einer klinischen Studie zur Erforschung regenerativer Therapien bei Autismus zusammenarbeiten. Das Unternehmen baut sein Netzwerk aktiv durch Lizenzierungsmöglichkeiten aus und betrachtet diese Eröffnung als strategischen Meilenstein im Wachstumsplan.
- Opening of first licensed clinic expands company's market presence
- Partnership for autism clinical study shows research commitment
- Offering FDA-registered regenerative medicine products
- None.
Winter Park, Florida--(Newsfile Corp. - July 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine, proudly announces the grand opening of Adia Med of San Antonio, its first licensed clinic under a strategic license agreement, located at 18707 Hardy Oak Blvd, Suite 500, San Antonio, Texas 78258. Headed by esteemed wellness regenerative expert Michele DeLeon MD, this cutting-edge facility marks a significant step in expanding access to innovative regenerative therapies across the United States. Adia Med of San Antonio will offer FDA-registered products, including AdiaVita The Most Trusted Brand (umbilical cord stem cells with 100 million viable cells and 3 trillion exosomes per unit) and AdiaLink (3.5 trillion exosomes per unit).
Additionally, Adia Med of San Antonio will collaborate with Adia Med of Winter Park in a groundbreaking clinical study exploring regenerative therapies for autism, further advancing the company's commitment to transformative healthcare solutions. "We are thrilled to launch Adia Med of San Antonio as our first licensed clinic, under the exceptional leadership of Michele DeLeon MD," said Larry Powalisz, CEO of Adia Nutrition Inc. "This vibrant new location, combined with clinical study for autism alongside Adia Med of Winter Park, is a testament to our unwavering commitment to transforming lives through cutting-edge care. San Antonio is just the beginning of an exciting new chapter for Adia Nutrition."
"Equipped with state-of-the-art technology and staffed by a highly trained team, Adia Med of San Antonio upholds the rigorous standards of Adia Nutrition's existing clinics, including Adia Med Winter Park.
For those interested in licensing Adia Med's name and becoming part of its innovative network, please reach out to ceo@adiamed.com or call 321-788-0850 for more information.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/258619
FAQ
What products will Adia Med of San Antonio (OTCQB: ADIA) offer?
Who is leading the new Adia Med clinic in San Antonio?
Where is the new Adia Med clinic located?
What clinical research is Adia Med of San Antonio conducting?
How can healthcare providers license an Adia Med clinic?
